BioRestorative Therapies, Inc. - Common Stock, $0.0001 par value (BRTX)

16 filings reported holding BRTX - BioRestorative Therapies, Inc. - Common Stock, $0.0001 par value as of Q3 2024.
BioRestorative Therapies, Inc. - Common Stock, $0.0001 par value (BRTX) has 15 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 269,756 shares of 8,896,104 outstanding shares and own 3.03% of the company stock.
Largest 10 shareholders include GEODE CAPITAL MANAGEMENT, LLC (55,706 shares), StoneX Group Inc. (52,529 shares), Wealth Alliance (40,000 shares), VANGUARD GROUP INC (20,472 shares), STATE STREET CORP (20,459 shares), RENAISSANCE TECHNOLOGIES LLC (20,000 shares), MORGAN STANLEY (17,500 shares), US FINANCIAL ADVISORS, LLC (17,142 shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (12,774 shares), and Newman Dignan & Sheerar, Inc. (10,522 shares).
This table shows the top 15 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.